Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2026-02-23 @ 12:20 PM
Study NCT ID:
NCT04167618
Status:
TERMINATED
Last Update Posted:
2023-10-06
First Post:
2019-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma
Sponsor:
Y-mAbs Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Medulloblastoma, Childhood | View |
Keywords: